Loading...
Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
SIMPLE SUMMARY: Myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) are two blood cancers with variable symptoms of low blood counts (fatigue, bleeding, infection risk) and risk of progression to acute myeloid leukemia. Management decisions should be guided by individual patien...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036734/ https://ncbi.nlm.nih.gov/pubmed/33807279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071610 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|